Physician profile
Brian Lane
NPI 1568442184
$19,065.16
in general payments reported to CMS, 2019-2025
24 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.75 · 2020: $92.87 · 2021: $19.70 · 2022: $435 · 2023: $13K · 2024: $4,386 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Travel and Lodging: $4,904 · Food and Beverage: $1,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,012.33 |
| Travel and Lodging | $4,903.90 |
| Food and Beverage | $1,568.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,823.15 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,748.82 | 2023 | |
| Medtronic, INC. | $1,259.12 | 2023 | Ligasure |
| Kerecis Limited | $298.85 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Novo Nordisk INC | $141.48 | 2024-2025 | |
| Conmed Corporation | $125.44 | 2025 | Airseal |
| Cook Medical LLC | $108.39 | 2025 | Hemospray |
| Csl Behring | $98.36 | 2021-2023 | Kcentra |
| Alexion Pharmaceuticals, INC. | $71.29 | 2022 | |
| W. L. Gore & Associates, INC. | $68.91 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $46.50 | 2023 | Andexxa |
| Ethicon US, LLC | $42.29 | 2023 | Echelon; Endopath |
| Portola Pharmaceuticals, LLC | $23.96 | 2020 | |
| Integra Lifesciences Corporation | $22.63 | 2022 | |
| Davol INC. | $21.98 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $21.31 | 2023 | Gattex |
| Edwards Lifesciences Corporation | $20.69 | 2023 | |
| Kci USA, INC. | $19.55 | 2022 | |
| Abbvie INC. | $19.18 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $18.46 | 2023 | Seglentis |
| Boston Scientific Corporation | $17.94 | 2019 | |
| Teleflex LLC | $17.03 | 2025 | Titan Sgs Bailout Chuck |
| Z-Medica, LLC | $15.81 | 2019 | |
| Acera Surgical, INC. | $14.02 | 2023 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.